Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-23-050220

Director sold 4,359 shares at $0.69 ($3,008)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ajer Jeffrey Robert Director 2023-09-18 Sale −4,359 $0.69 $3,008 34,153 D: show line 1 in the form
Open-market sales · 4,359 sh · avg $0.69 · $3,008

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ajer Jeffrey Robert Director 2023-09-19 Grant or award · Stock Option +85,000 85,000 D: show line 2 in the form
Loading xslF345X05/doc4.xml…